Two landmark international studies show that brain biomarkers can predict whether people with REM sleep behaviour disorder (iRBD) will develop Parkinson’s disease or dementia with Lewy bodies (DLB). MRI scans revealed that reduced glymphatic system function signals higher risk for Parkinson’s, while increased free water in the basal nucleus of Meynert predicts progression to DLB.